Anti-Adrenomedullin-Antikörper (ADM) oder Anti-ADM-Antikörperfragment oder non-Ig Anti-ADM-Proteingerüst zur Reduzierung des Sterblichkeitsrisikos bei einem Patienten mit chronischer oder akuter Erkrankung oder in einem akuten Zustand

European patent · EP2594587 · In force

Register entry

Publication number
EP2594587
Application number
EP12193118
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 16, 2012
Published
May 22, 2013
Granted
May 21, 2014
Protection ends at the latest
Nov 15, 2032
Next annual fee due
Nov 30, 2026
IPC classes
C07K 16/26 (2006.01)
A61K 39/395 (2006.01)
A61P 31/00 (2006.01)
A61P 9/00 (2006.01)
A61P 13/12 (2006.01)
Priority
EP 11189450 16.11.2011
EP 12160017 16.03.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Sep 22, 2021

    Transferred

    Owner
    AdrenoMed AG, Neuendorfstrasse 19a, 16761 Hennigsdorf, Germany → AdrenoMed AG, Neuendorfstrasse 15a, 16761 Hennigsdorf, Germany

    Published in Swissreg on 22.09.2021

  6. Nov 22, 2014

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 22.11.2014

  7. May 21, 2014

    Granted

    Published in Swissreg on 21.05.2014

Parties

Inventor

Bergmann, Andreas

13465 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.